Grand Round: Looking Forward to the Present: Incorporating Innovative Trial Methods and Practices to Inf...

Grand Round: Looking Forward to the Present: Incorporating Innovative Trial Methods and Practices to Inform Best Practice


October 01, 2019 - 12:00 - 13:00
Team: Events, Training & News
Posted on September 12, 2019

Grand Round: Looking Forward to the Present: Incorporating Innovative Trial Methods and Practices to Inform Best Practice

Team: Events, Training & News

October 01, 2019 - 12:00 - 13:00


Looking Forward to the Present: Incorporating Innovative Trial Methods  and Practices to Inform Best Practice

October 1, 2019
12:00 pm - 1:00 pm
Theatre B, Basic Medical Sciences Building,
University of Manitoba, 745 Bannatyne Ave.

YouTube live stream will be available here: 

Pre-registration is encouraged to expedite check-in.

 Add this event to your calendar.

Just as knowledge and treatments in medicine evolve, so have methods to conduct clinical trials. This session will introduce innovative clinical trial designs and provide practical examples of their use, advantages, and potential pitfalls.

Learning Objectives: 

  • Articulate current state and challenges of classical trial designs.
  • Discuss novel design methods.
  • Provide examples of innovative clinical trials being conducted locally and in Canada.
  • Highlight areas where innovative trial methods might be considered in Manitoba

Presenter: Ryan Zarychanski MD MSc. FRCPC

Associate Professor, 
Rady Faculty of Health Sciences, Max Rady College of Medicine, 
Departments of Internal Medicine,
Sections of Hematology/Medical Oncology and Critical Care,
and the Department of Community Health Sciences,
University of Manitoba, Winnipeg, Canada
Hematologist, CancerCare Manitoba;
Senior Scientist, Research Institute of Oncology and Hematology
Lyonel G Israels Research Professor of Hematology, University of Manitoba

Dr. Zarychanski is a Hematologist, Critical Care physician, and Clinician-Scientist at the University of Manitoba and CancerCare Manitoba. His research focuses on the hematologic aspects of critical illness. His major program of research is studying unfractionated heparin in septic shock—a program that has now culminated into an international randomized controlled trial. Other research programs evaluate the use of IVIG and plasma exchange in septic shock. Dr. Zarychanski leads the Acute Care Hematology Research Group at CancerCare Manitoba, a research cluster committed to training and mentoring the next generation of clinician scientists in Manitoba. He receives operating funding from the CIHR and CancerCare Manitoba, and serves as the Lyonel G Irsaels Professor of Hematology at the University of Manitoba.

 To transform how data is used in clinical practice and in research, Dr. Zarychanski is leading a Provincial effort and collaborative team to create an integrated real-time clinical data platform in the Province of Manitoba. As part of this process, he and colleagues are conducting several innovative clinical trials in perioperative medicine, nephrology, and oncology.

The monthly Society of Clinical Research Associates (SOCRA), Winnipeg Chapter session will be combined with this Grand Round. To ensure SoCRA members receive accreditation for their attendance, please sign-in using the SoCRA members sheet upon arrival, regardless if you have pre-registered. For any questions/inquiries regarding SoCRA, contact Tarpan Mankad, Clinical Trial Specialist, CHI, tarpan.mankad@umanitoba.


Documents and Photos

Web Links and Embedded Content